FABP4 and fatty liver disease: In fact, we observed that FABP4 expression was mainly determined by ATGL. VAT has a greater lipolytic potential than SAT, and the release of FFA from VAT directly into the portal circulation is one of the mechanisms involved in fatty liver disease and hepatic IR [38].